Please use this identifier to cite or link to this item:
- The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
- Med Univ S Carolina
- Universidade Estadual Paulista (UNESP)
- Periodontal disease initiation and progression occurs as a consequence of the host immune inflammatory response to oral pathogens. The innate and acquired immune systems are critical for the proper immune response. LPS, an outer membrane constituent of periodontal pathogenic bacteria, stimulates the production of inflammatory cytokines IL-1 beta TNF alpha IL-6 and RANKL either directly or indirectly. In LPS-stimulated cells, the induction of cytokine expression requires activation of several signaling pathways including the p38 MAPK pathway. This review will discuss the significance of the p38 MAPK pathway in periodontal disease progression and the potential therapeutic consequences of pharmacological antagonism of this pathway in the treatment of periodontal diseases.
- Current Drug Metabolism. Sharjah: Bentham Science Publ Ltd, v. 10, n. 1, p. 55-67, 2009.
- Bentham Science Publ Ltd
- Periodontal diseases
- p38 MAPK
- p38 inhibitors
- innate immunity
- bone loss
- experimental periodontitis
- Acesso restrito
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.